Scott M. Hammer, M treatment .D., Magdalena E. Sobieszczyk, M.D., M.P.H., Holly Janes, Ph.D., Shelly T. Karuna, M.D., Mark J. Mulligan, M.D., Doug Grove, M.S., Beryl A. Koblin, Ph.D., Susan P. Buchbinder, M.D., Michael C. Keefer, M.D., Georgia D. Tomaras, Ph.D., Nicole Frahm, Ph.D., John Hural, Ph.D., Chuka Anude, M.D., Ph.D., Barney S. Graham, M.D., Ph.D., Mary E. Enama, M.A., P.A.-C., Elizabeth Adams, M.D., Edwin DeJesus, M.D., Richard M. Novak, M.D., Ian Frank, M.D., Carter Bentley, Ph.D., Shelly Ramirez, M.A., Rong Fu, M.S., Richard A. Koup, M.D., John R. Mascola, M.D., Gary J. Nabel, M.D., Ph.D., David C. Montefiori, Ph.D., James Kublin, M.D., M.P.H., M. Juliana McElrath, M.D., Ph.D., Lawrence Corey, M.D., and Peter B. Gilbert, Ph.D. For the HVTN 505 Study Team: Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine The epidemic infection due to the human immunodeficiency virus type 1 is currently in its fourth 10 years, with an estimated 2.5 million new infections happening annually worldwide.
Paul Grootendorst, University of Toronto advisor and professor to CIHI.3 percent of prescribed drugs were paid for by the general public sector, rising to an anticipated 47.2 percent in 2003. Provincially, in 2003, the share varied from a low of 29.8 percent in Prince Edward Island to a high of 53.0 percent in Manitoba. Regardless of the differences, each territory and province increased its share of public financing between 1985 and 2001, apart from Nova Scotia, New Saskatchewan and Brunswick. Drug Expenditure per Capita Total drug expenditure per person in Canada was around $537 in 2001; it really is expected to reach $578 in 2002 and $620 in 2003.